Cargando…

The immune microenvironment landscape shows treatment-specific differences in rectal cancer patients

Neoadjuvant therapy is the cornerstone of modern rectal cancer treatment. Insights into the biology of tumor responses are essential for the successful implementation of organ-preserving strategies, as different treatments may lead to specific tumor responses. In this study, we aim to explore treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graham Martínez, Cristina, Barella, Yari, Kus Öztürk, Sonay, Ansems, Marleen, Gorris, Mark A.J, van Vliet, Shannon, Marijnen, Corrie A.M, Nagtegaal, Iris D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552175/ https://www.ncbi.nlm.nih.gov/pubmed/36238289 http://dx.doi.org/10.3389/fimmu.2022.1011498

Ejemplares similares

Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature
por: Swets, Marloes, et al.
Publicado: (2022)

Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study
por: Nagtegaal, Iris D, et al.
Publicado: (2001)

The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts
por: Ansems, Marleen, et al.
Publicado: (2020)

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
por: Nilsson, Per J, et al.
Publicado: (2013)

Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014
por: Punt, Cornelis JA, et al.
Publicado: (2015)

Mesorectal radiotherapy for early stage rectal cancer: A novel target volume
por: Peters, Femke P., et al.
Publicado: (2020)

Benchmarking daily adaptation using fully automated radiotherapy treatment plan optimization for rectal cancer
por: Jagt, Thyrza Z., et al.
Publicado: (2022)

Intra-Tumoral Genomic Heterogeneity in Rectal Cancer: Mutational Status Is Dependent on Preoperative Biopsy Depth and Location
por: Vuijk, Floris A., et al.
Publicado: (2021)

T(1ρ) for Radiotherapy Treatment Response Monitoring in Rectal Cancer Patients: A Pilot Study
por: Kooreman, Ernst S., et al.
Publicado: (2022)

Effect of intrafraction adaptation on PTV margins for MRI guided online adaptive radiotherapy for rectal cancer
por: Kensen, Chavelli M., et al.
Publicado: (2022)

Online Adaptive MRI-Guided Radiotherapy for Primary Tumor and Lymph Node Boosting in Rectal Cancer
por: Kensen, Chavelli M., et al.
Publicado: (2023)

Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer – A multicentre dose planning study
por: Appelt, Ane L., et al.
Publicado: (2019)

Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands
por: Raaijmakers, Tonke K., et al.
Publicado: (2018)

Validated Pretreatment Prediction Models for Response to Neoadjuvant Therapy in Patients with Rectal Cancer: A Systematic Review and Critical Appraisal
por: Tanaka, Max D., et al.
Publicado: (2023)

The Promises of Speeding Up: Changes in Requirements for Animal Studies and Alternatives during COVID-19 Vaccine Approval–A Case Study
por: Ritskes-Hoitinga, Merel, et al.
Publicado: (2022)

Gene expression profiling reveals two separate mechanisms regulating apoptosis in rectal carcinomas in vivo
por: de Bruin, Elza C., et al.
Publicado: (2007)

Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training
por: Sluckin, Tania C., et al.
Publicado: (2022)

Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus
por: Lambregts, Doenja M. J., et al.
Publicado: (2022)

Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
por: van der Woude, Lieke L, et al.
Publicado: (2022)

EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types
por: Rigter, Lisanne S., et al.
Publicado: (2019)

The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery
por: Bökkerink, Guus MJ, et al.
Publicado: (2011)

Contact X-ray Brachytherapy for Older or Inoperable Rectal Cancer Patients: Short-Term Oncological and Functional Follow-Up
por: Custers, Petra A., et al.
Publicado: (2021)

Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes
por: Detering, Robin, et al.
Publicado: (2018)

Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea
por: O'Cathail, Sean M., et al.
Publicado: (2023)

Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?
por: Stijns, Rutger, et al.
Publicado: (2019)

Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance
por: Graham Martinez, Cristina, et al.
Publicado: (2022)

Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results
por: Custers, Petra A., et al.
Publicado: (2022)

Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles
por: de Bruin, Elza C, et al.
Publicado: (2005)

Immunological Landscape and Clinical Management of Rectal Cancer
por: Pérez-Ruiz, Elísabeth, et al.
Publicado: (2016)

Visualizing movement in the tumor microenvironment landscape
por: Calvo, Veronica, et al.
Publicado: (2013)

Expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer
por: Span, P N, et al.
Publicado: (2009)

Umbilical metastases: Real‐world data shows abysmal outcome
por: Hugen, Niek, et al.
Publicado: (2021)

A model of Point 5 showing the landscaping
por: Jean-Luc Caron
Publicado: (1998)

Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study
por: Rombouts, Anouk J M, et al.
Publicado: (2017)

Impact of endorectal filling on interobserver variability of MRI based rectal primary tumor delineation
por: Lo Russo, Monica, et al.
Publicado: (2022)

The updated landscape of tumor microenvironment and drug repurposing
por: Jin, Ming-Zhu, et al.
Publicado: (2020)

Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy
por: Yang, Jie, et al.
Publicado: (2019)

The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients
por: Germani, Marco Maria, et al.
Publicado: (2022)

The proteomic landscape shows oncologic relevance in cystitis glandularis
por: Kim, Jun Yong, et al.
Publicado: (2023)

MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis
por: Meškytė, Erna Marija, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e1uv3k5toojvbs5uv99bu8j1qn